Mechanisms underlying the activation of cytotoxic function mediated by hepatic lymphocytes following the administration of glycyrrhizin

International Immunopharmacology

Volumn 2, Issue 8, 2002, Pages 1079-1086

  Miyaji, Chikako ^a   Miyakawa, Ryoko ^a   Watanabe, Hisami ^a   Kawamura, Hiroki ^a   Abo, Toru ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Cytotoxic function; Glycyrrhizin; Liver; NK cells; NKT cells

Indexed keywords

ANTIGEN; CD8 ANTIGEN; FAS LIGAND; GLYCYRRHIZIC ACID; NEOMINOPHAGEN C; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVATION; CELL ASSAY; CELL FUNCTION; CONTROLLED STUDY; CYTOTOXICITY; IMMUNIZATION; LIVER; LIVER CELL; LYMPHOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TIME; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; CYTOTOXICITY TEST; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METHODOLOGY;

ANIMAL; COMPARATIVE STUDY; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; GLYCYRRHIZIC ACID; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR; ANIMALS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035993211     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00033-4     Document Type: Article

References (20)

1. Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro
2. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV(HTLV-III/LAV)]
3. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV)
4. Effects of glycyrrhizin (SNMC: Stronger neo-minophagen C) in hemophilia patients with HIV-1 infection
5. Effects of glycyrrhizin (SNMC: Stronger neo-minophagen C) in hemophilia patients with HIV infection
6. Effect of glycyrrhizin on biochemical tests in patients with chronic hepatitis-double blind trial
7. Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis
8. Selective activation of extrathymic T cells in the liver by glycyrrhizin
9. Therapeutic effects of glycyrrhizin in mice infected with LP-BM5 murine retrovirus and mechanisms involved in the prevention of disease progression
10. Paradoxical effects of glycyrrhizin on the induction of granulocytes and extrathymic T cells between normal mice and mice with preexisting granulocytosis
11. -extrathymic T cells in the liver by injection of bone marrow cells isolated from mice with a mutation of polymorphic MHC antigens
12. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes
13. +T cells are present within a population of intermediate TCR cells
14. A comparison of proliferative response to IL-7 and expression of IL-7 receptors in intermediate TCR cells of the liver, spleen, and thymus
15. - subsets, using Fas ligand/Fas molecules
16. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity
17. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats
18. +T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells
19. The liver and the hematolymphoid system: I. The regulation of nylon-passed spleen cell proliferation by active factors released from syngeneic nonparenchymal liver cells
20. Expression of cytokines and factors modulating apoptosis by human sinusoidal leucocytes